215 related articles for article (PubMed ID: 19391168)
21. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
22. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
23. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
[TBL] [Abstract][Full Text] [Related]
24. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
[TBL] [Abstract][Full Text] [Related]
25. Is there a role for inherited TRβ mutation in human carcinogenesis? [corrected].
Weinert LS; Ceolin L; Romitti M; Camargo EG; Maia AL
Arq Bras Endocrinol Metabol; 2012 Feb; 56(1):67-71. PubMed ID: 22460197
[TBL] [Abstract][Full Text] [Related]
26. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta.
O'Shea PJ; Bassett JH; Sriskantharajah S; Ying H; Cheng SY; Williams GR
Mol Endocrinol; 2005 Dec; 19(12):3045-59. PubMed ID: 16051666
[TBL] [Abstract][Full Text] [Related]
27. Germline and somatic thyroid hormone receptor mutations in man.
Yen PM; Cheng SY
J Endocrinol Invest; 2003 Aug; 26(8):780-7. PubMed ID: 14669837
[TBL] [Abstract][Full Text] [Related]
28. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.
Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY
Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418
[TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone receptor mutations and disease: insights from knock-in mouse models.
Cheng SY
Expert Rev Endocrinol Metab; 2007 Jan; 2(1):47-57. PubMed ID: 30743748
[TBL] [Abstract][Full Text] [Related]
30. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
31. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
[TBL] [Abstract][Full Text] [Related]
32. Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone.
Ying H; Furuya F; Willingham MC; Xu J; O'Malley BW; Cheng SY
Mol Cell Biol; 2005 Sep; 25(17):7687-95. PubMed ID: 16107715
[TBL] [Abstract][Full Text] [Related]
33. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.
Cheng SY
Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829
[TBL] [Abstract][Full Text] [Related]
34. Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.
Ichijo S; Furuya F; Shimura H; Hayashi Y; Takahashi K; Ohta K; Kobayashi T; Kitamura K
PLoS One; 2014; 9(12):e116252. PubMed ID: 25548921
[TBL] [Abstract][Full Text] [Related]
35. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY
Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
37. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
38. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
Suzuki H; Willingham MC; Cheng SY
Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
[TBL] [Abstract][Full Text] [Related]
39. Autonomous functions of murine thyroid hormone receptor TRα and TRβ in cochlear hair cells.
Dettling J; Franz C; Zimmermann U; Lee SC; Bress A; Brandt N; Feil R; Pfister M; Engel J; Flamant F; Rüttiger L; Knipper M
Mol Cell Endocrinol; 2014 Jan; 382(1):26-37. PubMed ID: 24012852
[TBL] [Abstract][Full Text] [Related]
40. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]